Merck & Company, Inc.
MRK · NYSE · USD
$142.38
−0.41 −0.29%todayNot financial advice.
- Open
- 141.90
- Day range
- 138.89 - 142.77
- 52-week range
- 82.01 - 156.92
- Volume
- 8.41M
- Market cap
- 351.28B
- P/E ratio
- 113.8
- EPS
- 1.26
- Dividend yield
- 2.38%
- Beta
- -0.24
Performance
W
−1.61%
1M
−4.06%
3M
+13.79%
6M
+15.79%
YTD
+34.92%
Y
+61.92%
5Y
+74.34%
All
+36.1K%
In the news
Oct 8
Halozyme Wins European Court Order Blocking Merck's Keytruda SC
A Dutch court blocked Merck from selling its subcutaneous Keytruda in eight European nations, giving Halozyme a key patent victory.
Company news
Oct 8
Cantor Fitzgerald Raises Price Targets for Eli Lilly, Pfizer, and Merck
Cantor Fitzgerald raised price targets for Eli Lilly, Pfizer, and Merck, highlighting drug pipelines and growth prospects.
Analyst ratings
Oct 7
Tempus AI Expands Cancer Vaccine Collaboration With Moderna and Merck
Tempus AI expanded its partnership with Moderna and Merck to support the potential commercialization of an individualized cancer therapy.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NYSE-MRK" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Merck & Company, Inc. (MRK) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NYSE-MRK">MRK stock price</a> by FreeTheAI Stocks</p>